Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease Page 1 Global
Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review D. Rebecca …

BACKGROUND Non-tuberculous pulmonary disease (NTM-PD) is widely underdiagnosed
and certain patient groups, such as those with underlying respiratory diseases, are at …

Background Gastroesophageal reflux disease (GERD) is a common comorbidity of
nontuberculous mycobacteria (NTM) pulmonary disease (PD). Although GERD is associated …

Asthma is chronic eosinophilic bronchitis with the dominancy of T helper 2 (Th2)
inflammation. However, patients with asthma and metabolic dysfunction have pathogenic …

Introduction Over the last ten years an increasing prevalence and incidence of non-
tuberculous mycobacteria (NTM) has been reported among patients with cystic fibrosis (CF) …

BACKGROUND Nontuberculous mycobacterial (NTM) pulmonary disease is increasing
globally. 1 Pulmonary infections are typically opportunistic and associated with immune …

Background Nontuberculous mycobacteria are environmental organisms that cause
infections leading to chronic, debilitating pulmonary disease, among which Mycobacterium …

Background The global prevalence and incidence of nontuberculous mycobacteria (NTM)
infection are increasing. However, the prevalence of NTM infection-associated comorbidities …

Objectives Semi-quantitative CT score is generally used for evaluating the disease status of
Mycobacterium abscessus (Mab) Pulmonary disease (Mab-PD). However, its accuracy and …

Introduction Management of nontuberculous mycobacterial lung disease (NTM-LD) can be
encumbered by difficult diagnostic criteria and complex treatment decisions. As prevalence …